反応式
[Br-].[CH2:2]([N:4]([C:7]1[O:8][C:9]2[CH:15]=[C:14]([C:16]3[CH:21]=[CH:20]C=CC=3[P+](C)(C3C=CC=CC=3)C3C=CC=CC=3)[CH:13]=[CH:12][C:10]=2[N:11]=1)C=O)[CH3:3].[CH2:36]([N:43]1[CH:47]=[CH:46][N:45]=C1C=O)[C:37]1[CH:42]=[CH:41][CH:40]=[CH:39][CH:38]=1.CC(C)([O-])C.[K+]>O1CCCC1>[CH2:36]([N:43]1[CH:47]=[CH:46][N:45]=[C:20]1[CH:21]=[CH:16][C:14]1[CH:13]=[CH:12][C:10]2[N:11]=[C:7]([NH:4][CH2:2][CH3:3])[O:8][C:9]=2[CH:15]=1)[C:37]1[CH:42]=[CH:41][CH:40]=[CH:39][CH:38]=1参加物
5
実験手順
A mixture of [2-(N-ethylformamido)benzoxazol-6-yl]-methyltriphenylphosphonium bromide (0.5 g), 1-benzyl-2-imidazolecarbaldehyde (0.2 g) and potassium tert-butoxide (0.1 g) in tetrahydrofuran (5.0 ml) was refluxed for 50 minutes. Evaporation of a solvent gave a residue, which was purified by a column chromatography on silica gel eluting with a mixture of chloroform and methanol (19:1, V/V). The eluted fractions containing the desired product were collected and evaporated in vacuo to give 6-[2-(1-benzylimidazol-2-yl)vinyl]-2-ethylaminobenzoxazole (0.2 g).
後処理
- temperaturewas refluxed for 50 minutes
- customEvaporation of a solvent
- customgave a residue, which
- customwas purified by a column chromatography on silica gel eluting with a mixture of chloroform and methanol (19:1, V/V)
- additionThe eluted fractions containing the desired product
- customwere collected
- customevaporated in vacuo
出典と根拠
- ORDレコード
- ord-5278b472a91b4f3f8c1b2079ffd73702
- 出典データセット
- uspto-grants-1991_09
- 特許番号
- US05047411
関連ノート
読み込み中…